Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Adaptimmune TherapeuticsNantkwestTranslate BioAutolus TherapeuticsVoyager Therapeutics
SymbolNASDAQ:ADAPNASDAQ:NKNASDAQ:TBIONASDAQ:AUTLNASDAQ:VYGR
Price Information
Current Price$3.66$4.68$7.25$8.60$10.60
52 Week RangeBuySellBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuySellBuyBuyBuy
Consensus Price Target$6.03$1.00$20.75$25.00$28.00
% Upside from Price Target64.75% upside-78.63% downside186.21% upside190.70% upside164.15% upside
Trade Information
Market Cap$383.17 million$451.52 million$435.16 million$366.13 million$396.28 million
Beta1.472.780.850.882.51
Average Volume2,964,7182,686,921219,272201,936314,111
Sales & Book Value
Annual Revenue$59.51 million$50,000.00$1.42 million$1.41 million$7.62 million
Price / Sales6.449,207.15306.45244.8651.57
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.36 per share$1.84 per share$2.78 per shareN/A$1.43 per share
Price / Book1.552.542.617.41
Profitability
Net Income$-95,510,000.00$-96,230,000.00$-97,390,000.00$-12,860,000.00$-88,290,000.00
EPS($0.96)($1.22)($3.64)($1.42)($2.75)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-164,604.89%-1,732.61%-3,576.93%-72.64%
Return on Equity (ROE)-71.88%-44.91%-59.18%-39.54%-57.32%
Return on Assets (ROA)-57.88%-37.18%-25.17%-33.58%-15.83%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.15%0.09%0.62%0.09%N/A
Current Ratio3.93%5.72%8.62%12.65%4.09%
Quick Ratio3.93%5.72%8.62%12.65%4.09%
Ownership Information
Institutional Ownership Percentage54.88%5.85%86.28%24.55%85.69%
Insider Ownership Percentage22.36%71.73%15.40%N/A33.60%
Miscellaneous
Employees40616181N/A123
Shares Outstanding104.69 million98.37 million60.02 million40.15 million37.07 million
Next Earnings DateN/A3/11/2020 (Estimated)3/19/2020 (Estimated)3/3/2020 (Confirmed)3/3/2020 (Confirmed)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel